195 related articles for article (PubMed ID: 12115186)
1. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.
Huang W; Sinha J; Newman J; Reddy B; Budhai L; Furie R; Vaishnaw A; Davidson A
Arthritis Rheum; 2002 Jun; 46(6):1554-62. PubMed ID: 12115186
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
3. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
6. Limiting dilution analysis of Epstein-Barr virus infectable B cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus and systemic lupus erythematosus.
Isacovics B; Silverman ED
J Autoimmun; 1993 Aug; 6(4):481-94. PubMed ID: 8216690
[TBL] [Abstract][Full Text] [Related]
7. Usage of a novel class of germ-line Ig variable region gene for cationic anti-DNA autoantibodies in human lupus nephritis and its role for the development of the disease.
Harada T; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1994 Nov; 153(10):4806-15. PubMed ID: 7963546
[TBL] [Abstract][Full Text] [Related]
8. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
9. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Boumpas DT; Furie R; Manzi S; Illei GG; Wallace DJ; Balow JE; Vaishnaw A;
Arthritis Rheum; 2003 Mar; 48(3):719-27. PubMed ID: 12632425
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
12. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
13. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I
Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of IgG anti-DNA-secreting B cells in patients with systemic lupus erythematosus.
Klinman DM; Shirai A; Conover J; Steinberg AD
Eur J Immunol; 1994 Jan; 24(1):53-8. PubMed ID: 8020571
[TBL] [Abstract][Full Text] [Related]
15. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.
Sfikakis PP; Souliotis VL; Fragiadaki KG; Moutsopoulos HM; Boletis JN; Theofilopoulos AN
Clin Immunol; 2007 Apr; 123(1):66-73. PubMed ID: 17275413
[TBL] [Abstract][Full Text] [Related]
17. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus.
Nakamura N; Azuma C; Akamizu T; Sugawa H; Matsuda F; Mitsuda N; Honjo T; Mori T; Yamaji K
Biochem Biophys Res Commun; 1994 Sep; 203(3):1789-94. PubMed ID: 7945329
[TBL] [Abstract][Full Text] [Related]
19. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
20. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.
Jacobi AM; Reiter K; Mackay M; Aranow C; Hiepe F; Radbruch A; Hansen A; Burmester GR; Diamond B; Lipsky PE; Dörner T
Arthritis Rheum; 2008 Jun; 58(6):1762-73. PubMed ID: 18512812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
